Cargando…

The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis

Bone is the most common site for breast cancer spread. In the pro-metastatic cell line 1833, derived from MDA-MB-231 breast adenocarcinoma cells, both hypoxia and hepatocyte growth factor (HGF) influence the effect of miR-125b on ETS proto-oncogene 1 transcription factor (ETS1). The effect of hypoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maroni, Paola, Bendinelli, Paola, Matteucci, Emanuela, Desiderio, Maria Alfonsina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920088/
https://www.ncbi.nlm.nih.gov/pubmed/29700305
http://dx.doi.org/10.1038/s41419-018-0499-8
_version_ 1783317762534277120
author Maroni, Paola
Bendinelli, Paola
Matteucci, Emanuela
Desiderio, Maria Alfonsina
author_facet Maroni, Paola
Bendinelli, Paola
Matteucci, Emanuela
Desiderio, Maria Alfonsina
author_sort Maroni, Paola
collection PubMed
description Bone is the most common site for breast cancer spread. In the pro-metastatic cell line 1833, derived from MDA-MB-231 breast adenocarcinoma cells, both hypoxia and hepatocyte growth factor (HGF) influence the effect of miR-125b on ETS proto-oncogene 1 transcription factor (ETS1). The effect of hypoxia inducible factor 1 alpha subunit (HIF1A), known to promote metastatic spread by upregulating prostaglandin endoperoxide synthase 2 (PTGS2), may be dampened by miR-125b targeting PTGS2. Here, we investigated whether miR-125b plays a role in breast cancer metastasis by measuring its activity in response to the chemotherapeutic agent NS-398 in a xenograft model. NS-398 is typically used in the clinic to target PTGS2. We also aimed to describe the molecular mechanisms in vitro, since the enhancement of epithelial properties may favor the efficacy of therapies. We report that in the xenograft model, miR-125b reduced metastasis to the bone. We also report suppression of PTGS2 enhanced survival by decreasing HIF1A in cells within the bone marrow. In 1833 cells transfected with a miR-125b mimic we observed several phenotypic changes including enhancement of the epithelial marker E-cadherin, a reduction of mesenchymal-associated genes and a reduction of WNT-associated stem cell signaling. Our findings suggest that in vivo, key players of the bone microenvironment promoting breast cancer spread are regulated by miR-125b. In future, biological molecules imitating miR-125b may enhance the sensitivity of chemotherapeutic agents used to counteract bone metastases.
format Online
Article
Text
id pubmed-5920088
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59200882018-06-07 The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis Maroni, Paola Bendinelli, Paola Matteucci, Emanuela Desiderio, Maria Alfonsina Cell Death Dis Article Bone is the most common site for breast cancer spread. In the pro-metastatic cell line 1833, derived from MDA-MB-231 breast adenocarcinoma cells, both hypoxia and hepatocyte growth factor (HGF) influence the effect of miR-125b on ETS proto-oncogene 1 transcription factor (ETS1). The effect of hypoxia inducible factor 1 alpha subunit (HIF1A), known to promote metastatic spread by upregulating prostaglandin endoperoxide synthase 2 (PTGS2), may be dampened by miR-125b targeting PTGS2. Here, we investigated whether miR-125b plays a role in breast cancer metastasis by measuring its activity in response to the chemotherapeutic agent NS-398 in a xenograft model. NS-398 is typically used in the clinic to target PTGS2. We also aimed to describe the molecular mechanisms in vitro, since the enhancement of epithelial properties may favor the efficacy of therapies. We report that in the xenograft model, miR-125b reduced metastasis to the bone. We also report suppression of PTGS2 enhanced survival by decreasing HIF1A in cells within the bone marrow. In 1833 cells transfected with a miR-125b mimic we observed several phenotypic changes including enhancement of the epithelial marker E-cadherin, a reduction of mesenchymal-associated genes and a reduction of WNT-associated stem cell signaling. Our findings suggest that in vivo, key players of the bone microenvironment promoting breast cancer spread are regulated by miR-125b. In future, biological molecules imitating miR-125b may enhance the sensitivity of chemotherapeutic agents used to counteract bone metastases. Nature Publishing Group UK 2018-04-27 /pmc/articles/PMC5920088/ /pubmed/29700305 http://dx.doi.org/10.1038/s41419-018-0499-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Maroni, Paola
Bendinelli, Paola
Matteucci, Emanuela
Desiderio, Maria Alfonsina
The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title_full The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title_fullStr The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title_full_unstemmed The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title_short The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
title_sort therapeutic effect of mir-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ets1 in the context of the microenvironment of bone metastasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920088/
https://www.ncbi.nlm.nih.gov/pubmed/29700305
http://dx.doi.org/10.1038/s41419-018-0499-8
work_keys_str_mv AT maronipaola thetherapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT bendinellipaola thetherapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT matteucciemanuela thetherapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT desideriomariaalfonsina thetherapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT maronipaola therapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT bendinellipaola therapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT matteucciemanuela therapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis
AT desideriomariaalfonsina therapeuticeffectofmir125bisenhancedbytheprostaglandinendoperoxidesynthase2cyclooxygenase2blockadeandhampersets1inthecontextofthemicroenvironmentofbonemetastasis